Machin D - Search Results

1

Neoadjuvant and adjuvant therapy for surgical resection of hepatocellular carcinoma.

Samuel M, Chow PK, Chan Shih-Yen E, Machin D, Soo KC. Samuel M, et al. Among authors: machin d. Cochrane Database Syst Rev. 2009 Jan 21;2009(1):CD001199. doi: 10.1002/14651858.CD001199.pub2. Cochrane Database Syst Rev. 2009. PMID: 19160192 Free PMC article.

2

Neoadjuvant and adjuvant therapy for operable hepatocellular carcinoma.

Chan ES, Chow PK, Tai B, Machin D, Soo K. Chan ES, et al. Among authors: machin d. Cochrane Database Syst Rev. 2000;(2):CD001199. doi: 10.1002/14651858.CD001199. Cochrane Database Syst Rev. 2000. Update in: Cochrane Database Syst Rev. 2009 Jan 21;(1):CD001199. doi: 10.1002/14651858.CD001199.pub2. PMID: 10796754 Updated.

3

High-dose tamoxifen in the treatment of inoperable hepatocellular carcinoma: A multicenter randomized controlled trial.

Chow PK, Tai BC, Tan CK, Machin D, Win KM, Johnson PJ, Soo KC; Asian-Pacific Hepatocellular Carcinoma Trials Group. Chow PK, et al. Among authors: machin d. Hepatology. 2002 Nov;36(5):1221-6. doi: 10.1053/jhep.2002.36824. Hepatology. 2002. PMID: 12395333 Clinical Trial.

4

Use of tamoxifen in hepatocellular carcinoma: a review and paradigm shift.

Tan CK, Chow PK, Findlay M, Wong C, Machin D. Tan CK, et al. Among authors: machin d. J Gastroenterol Hepatol. 2000 Jul;15(7):725-9. doi: 10.1046/j.1440-1746.2000.02235.x. J Gastroenterol Hepatol. 2000. PMID: 10937676 Review.

5

Tamoxifen in hepatocellular carcinoma.

Chow P, Kiat TC, Choo TB, Machin D. Chow P, et al. Among authors: machin d. Lancet. 1998 Sep 5;352(9130):819-20. doi: 10.1016/S0140-6736(05)60715-5. Lancet. 1998. PMID: 9737316 Clinical Trial. No abstract available.

6

On developing a pragmatic strategy for clinical trials: A case study of hepatocellular carcinoma.

Gandhi M, Tan SB, Chung Yaw Fui A, Machin D. Gandhi M, et al. Among authors: machin d. Contemp Clin Trials. 2015 Jul;43:252-9. doi: 10.1016/j.cct.2015.06.018. Epub 2015 Jun 23. Contemp Clin Trials. 2015. PMID: 26111924

7

Elicitation of prior distributions for a phase III randomized controlled trial of adjuvant therapy with surgery for hepatocellular carcinoma.

Tan SB, Chung YF, Tai BC, Cheung YB, Machin D. Tan SB, et al. Among authors: machin d. Control Clin Trials. 2003 Apr;24(2):110-21. doi: 10.1016/s0197-2456(02)00318-5. Control Clin Trials. 2003. PMID: 12689733 Clinical Trial.

8

Following a trial that stopped early: what next for adjuvant hepatic intra-arterial iodine-131 lipiodol in resectable hepatocellular carcinoma?

Tan SB, Machin D, Cheung YB, Chung YF, Tai BC, Machin D. Tan SB, et al. Among authors: machin d. J Clin Oncol. 2002 Mar 15;20(6):1709. doi: 10.1200/JCO.2002.20.6.1709. J Clin Oncol. 2002. PMID: 11896125 No abstract available.

9

On the issue of 'multiple' first failures in competing risks analysis.

Tai BC, White IR, Gebski V, Machin D. Tai BC, et al. Among authors: machin d. Stat Med. 2002 Aug 15;21(15):2243-55. doi: 10.1002/sim.1208. Stat Med. 2002. PMID: 12210636

10

On the importance of accounting for competing risks in pediatric cancer trials designed to delay or avoid radiotherapy: I. Basic concepts and first analyses.

Tai BC, Grundy RG, Machin D. Tai BC, et al. Among authors: machin d. Int J Radiat Oncol Biol Phys. 2010 Apr;76(5):1493-9. doi: 10.1016/j.ijrobp.2009.03.035. Epub 2009 Jul 4. Int J Radiat Oncol Biol Phys. 2010. PMID: 19577860

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

387 results

Search Page

Filters